Clarus Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,433
Closed -$354K 131
2019
Q4
$354K Buy
2,433
+66
+3% +$8.95K 0.23% 98
2019
Q3
$306K Buy
2,367
+216
+10% +$28.5K 0.22% 94
2019
Q2
$300K Buy
2,151
+207
+11% +$28.7K 0.22% 77
2019
Q1
$272K Sell
1,944
-1,050
-35% -$141K 0.2% 69
2018
Q4
$386K Buy
2,994
+250
+9% +$34.9K 0.61% 24
2018
Q3
$379K Buy
2,744
+314
+13% +$41.7K 0.25% 45
2018
Q2
$311K Hold
2,430
0.24% 47
2018
Q1
$311K Sell
2,430
-2,151
-47% -$291K 0.29% 47
2017
Q4
$640K Buy
+4,581
New +$638K 0.62% 23

Other funds holding JNJ

Clarus Wealth Advisors's JNJ Position: Q1 2020 in Review

Clarus Wealth Advisors sold out of Johnson & Johnson (JNJ) in Q1 2020, closing a stake of 2,433 shares — an estimated $354K sold.

Clarus Wealth Advisors first reported a position in JNJ in Q4 2017 and held it in 9 quarters. The position peaked at $640K in Q4 2017. 2,932 funds tracked by Wall St. Rank hold JNJ as of Q1 2020.

  • Clarus Wealth Advisors reported no remaining Johnson & Johnson position as of Q1 2020 after selling out during the quarter.
  • Clarus Wealth Advisors sold 2,433 Johnson & Johnson shares in Q1 2020, an estimated $354K.
  • Clarus Wealth Advisors first reported a position in Johnson & Johnson in Q4 2017 and held it in 9 quarters.
  • Clarus Wealth Advisors's Johnson & Johnson position peaked at $640K in Q4 2017.
  • 2,932 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2020.

Based on Clarus Wealth Advisors's 13F filing for Q1 2020, filed 8 Apr 2020.